Clinical Trials

Dr. Wang and her Roswell Park colleagues travel the world to identify new clinical trials for leukemia for our patients at Roswell Park. "Our patients should have access to the same trials as patients in Boston, New York, Chicago and San Francisco."

Dr. Lee says hopes are high for the success of immunotherapies targeting multiple myeloma: “I think we’re seeing a major change in the way we take care of the disease.”

In 2012, Laurie Rich, PhD, arrived at Roswell Park to begin his doctoral work under the mentorship of Mukund Seshadri, PhD, DDS, Chair of Oral Oncology. He arrived at the same time as a very important piece of equipment, and as some crucial research was taking place.

Many different kinds of psychological interventions can help cancer patients deal with the physical and emotional symptoms of cancer and its treatment. One type of intervention that has shown great promise is mindfulness, and a mindfulness study is now open at Roswell Park for patients with advanced breast cancer.

Roswell Park is one of very few institutions in the United States equipped to offer clinical trials of a full range of immunotherapies. How do these treatments work, and what new immunotherapy clinical trials are underway or close to being launched?

Clinical trials are a key reason why childhood cancer treatments and survival rates have improved significantly in recent years.

“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."

Collected last week from a patient with late-stage ovarian cancer, these are not ordinary T cells; they have been altered and multiplied in the hope that when they are given back to her, they will launch a devastating attack on her cancer cells.

Find out what "orphan drug status" is and what it means for the cancer vaccine SurVaxM, currently under development at Roswell Park.

Ten years ago, patients diagnosed with advanced-stage kidney cancer had few options, and none of them were very promising. But in recent years, we have seen a revolution in kidney cancer treatment with ten new targeted drugs winning FDA approval.

On her 25th anniversary of being cancer-free, breast cancer survivor, Heidi Fornes, reflects on her diagnosis and how her outlook changed when she decided to spend just one day with Roswell Park.

When it comes to medical treatments, we’re not all alike. Women and men sometimes need different dosages of the same drug. One drug for heart failure works very well in black patients but not in white patients.